Alternative methods to traditional viability assays
Analysis of cell viability is an important aspect of many different studies in the fields of drug discovery, cancer research, and toxicology. Traditional assays, such as the MTT assay, neutral red uptake assay, or ATP bioluminescence assay are widely used to analyze cell viability. However, the major downside of these assays is that they are endpoint assays. Recently, more and more research labs realize the importance of kinetics in cell viability and cytotoxicity studies. Therefore, there is an increasing demand for methods that can, non-invasively, investigate changes in cell viability over time. Live-cell imaging is one of these non-invasive methods that enable monitoring of the dynamic changes in viability throughout the duration of an experiment.
In this webinar, CytoSMART has partnered with prominent labs from academia to facilitate an open discussion about the use of live-cell imaging for viability analysis. We will be covering:
Webinar details
Speakers
Dr. Alexander Weng, Senior Scientist, Freie Universität Berlin. Presentation: "A new acetylated triterpene saponin from Agrostemma githago L. modulates gene delivery efficiently and shows a high cellular tolerance"
Dr. Catarina Roma-Rodrigues, Postdoctoral Fellow FCT-NOVA, Universidade NOVA de Lisboa. Presentation: "Colorectal 3D spheroids as models for combined anti-cancer therapies"
Lieke Stemkens, MSc., Application Scientist, CytoSMART Technologies. Presentation: "How to use fluorescence live-cell imaging to unravel the dynamic apoptosis process"